Venus Remedies Limited (NSE:VENUSREM) Annual Report 2014



The latest annual report of Venus Remedies Limited (VENUSREM) was published on 31 Mar 2014. An annual report is a document that public corporations must provide annually to shareholders that describes their operations and financial conditions. Typically, an annual report will contain sections such as General corporate information, Operating and Financial highlights, Letter to shareholders from the CEO, Financial statements etc.

Key Statistics - VENUSREM Annual Results

Amounts in INR

Total Revenue
₹5.26B
Gross Profit
₹3.31B
EBIT
₹1.21B
Net Tangible Assets
₹5.94B
Net Income
₹609.50M
Capital Expenditures
-

VENUSREM Income Statement 2014 Annual Report

As per the latest Income Statement of VENUSREM, the Net revenue increased by ₹647.17M (14%) compared to the previous period. The operating income in 2014 increased by - (-). The net income as per the annual report was ₹609.50M which increased by - (-) compared to previous year.

Income Statement Report (2014/2013)

2014 2013
Total Revenue ₹5.26B ₹4.61B
Gross Profit ₹3.31B ₹3.31B
Operating Income - -
Income Before Tax - -
Net Income ₹609.50M ₹0.00

Balance Sheet - VENUSREM 2014 Annual Report

Read further: VENUSREM Balance Sheet Detailed Analysis

The latest balance sheet from annual result of Venus Remedies Limited showed the company increased the cash on balance sheet by ₹0.00 (0%). The Net tangible assets of VENUSREM on the balance sheet were at ₹5.94B which is ₹0.00 (0%) more than previous annual report. The total stockholder equity also increased by - (-) compared to previous reporting period.

Balance Sheet Statement Report (2014/2013)

2014 2013
Cash ₹2.36B ₹2.36B
Total Assets - -
Long Term Debt - -
Total Liabilities ₹143.80M ₹143.80M
Total Shareholder Equity - -
Net Tangible Assets ₹5.94B ₹5.94B

Cash Flow Statement - VENUSREM 2014 Annual Report

The 2014 annual cash flow statement of Venus Remedies Limited showed that the net income increased by - (-) compared to previous reporting period. Also the capital expenditure of VENUSREM increased by - (-).

As of 2014, the total cash from investing activities was - and total cash from financing activities was -.

Cash Flow Statement Report (2014/2013)

2014 2013
Net Income ₹609.50M ₹0.00
Capital Expenditures - -
Dividends Paid - -
Total Cash From From Investing Activities - -
Total Cash From From Financing Activities - -

Venus Remedies Limited Annual Report History

Income Statement

Income Statement history of Venus Remedies Limited (NSE:VENUSREM)

31 Mar 2014 31 Mar 2013 31 Mar 2011 31 Mar 2010
Total Revenue ₹5.26B ₹4.61B ₹3.58B ₹3.12B
Cost Of Revenue ₹0.00 ₹0.00 ₹0.00 ₹0.00
Gross Profit ₹0.00 ₹0.00 ₹0.00 ₹0.00
Research Development - - - -
Selling General Administrative - - - -
Non Recurring - - - -
Other Operating Expenses - - - -
Total Operating Expenses ₹0.00 ₹0.00 ₹0.00 ₹0.00
Operating Income - - - -
Total Other Income Expense Net - - - -
Ebit ₹0.00 ₹0.00 ₹0.00 ₹0.00
Interest Expense - - - -
Income Before Tax - - - -
Income Tax Expense ₹0.00 ₹0.00 ₹0.00 ₹0.00
Minority Interest - - - -
Net Income From Continuing Ops - - - -
Discontinued Operations - - - -
Extraordinary Items - - - -
Effect Of Accounting Charges - - - -
Other Items - - - -
Net Income ₹609.50M ₹0.00 ₹0.00 ₹0.00
Net Income Applicable To Common Shares - - - -

Balance Sheet Statement

Balance Sheet Statement history of Venus Remedies Limited (NSE:VENUSREM)

31 Mar 2014 31 Mar 2013 31 Mar 2011 31 Mar 2010
Cash ₹2.36B ₹2.36B - -
Total Assets - - - -
Total Liab ₹143.80M ₹143.80M - -
Long Term Debt - - - -
Total Stockholder Equity - - - -
Net Tangible Assets ₹5.94B ₹5.94B - -

Cash Flow Statement

Cash Flow Statement history of Venus Remedies Limited (NSE:VENUSREM)

31 Mar 2014 31 Mar 2013 31 Mar 2011 31 Mar 2010
Net Income ₹609.50M ₹0.00 - -
Capital Expenditures - - - -
Dividends Paid - - - -
Total Cashflows From Investing Activities - - - -
Total Cash From Financing Activities - - - -